Delia Deschaine is a Member of the Firm in the Health Care and Life Sciences practice and focuses her practice on the regulation of pharmaceutical and biotechnology. She routinely advises clients on matters involving the U.S. Food and Drug Administration, the U.S. Drug Enforcement Administration, and state boards of pharmacy. She began her career as a fellow in the U.S. Attorney General’s Honors Program and defends clients in civil, criminal, and administrative investigations and litigation.  She also conducts internal investigations and diligence in corporate transactions.  She is part of the firm’s post-Roe task force and co-lead of the firm’s Dobbs Procedural and Enforcement Working Group. View more here.